Maravai Lifesciences Holdings Inc Cl A (MRVI)

$3.86 -0.02 (-0.52%)
Market Cap 869.40M
Revenue (ttm) 259.19M
Net Income (ttm) -144.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -55.89%
Debt to Equity Ratio 0.68
Volume 1,015,100
Avg Vol 1,412,884
Day's Range N/A - N/A
Shares Out 255.71M
Stochastic %K 81%
Beta 0.33
Analysts Sell
Price Target $4.25

Company Profile

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleosid...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 546 0004
Address:
10770 Wateridge Circle, Suite 200, San Diego, United States
johnkimble
johnkimble Jan. 7 at 2:02 PM
$MRVI she is just getting started here comes the breakout!
0 · Reply
DARKP00L
DARKP00L Jan. 5 at 7:34 PM
$MRVI this stock is seeing a surge in interest. Market volatility might ensue!
0 · Reply
JohnStocksNY
JohnStocksNY Jan. 3 at 5:05 PM
Aptamer has signed a licensing agreement with $MRVI and stock (of Aptamer) has gained 36.7%
0 · Reply
JohnStocksNY
JohnStocksNY Jan. 3 at 4:59 PM
Wells Fargo Maintains Overweight on $MRVI
0 · Reply
SecessionS
SecessionS Dec. 25 at 2:36 PM
$MRVI The investment case increasingly rests on operational credibility rather than long‑range promises. Execution gaps should narrow meaningfully over coming quarters. Momentum becomes sustainable only with dependable execution. In short, this remains an execution‑driven story with meaningful but conditional upside.
2 · Reply
johnkimble
johnkimble Dec. 24 at 11:36 AM
$MRVI a sleeper stock going over $8 next year
1 · Reply
InvestorWisdom
InvestorWisdom Dec. 22 at 4:01 PM
$MRVI new product gaining traction. Upcoming reports should prove the growth trend… “We expect TriLink to deliver double digit sequential revenue growth in the fourth quarter," said Bernd Brust, CEO, Maravai LifeSciences. “The work we’ve done to reset, refocus, and strengthen the company positions us to deliver attractive financial results in the fourth quarter and 2026 while continuing to serve our customers with the same level of dedication we’ve had in the past."
0 · Reply
johnkimble
johnkimble Dec. 19 at 6:12 AM
$MRVI we will be adding some more with a target over $7
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:26 PM
Wells Fargo has updated their rating for Maravai LifeSciences ( $MRVI ) to Overweight with a price target of 4.5.
0 · Reply
CopiousCope
CopiousCope Dec. 11 at 9:18 PM
$MIGI next is $MRVI hidden gem imo been in
0 · Reply
Latest News on MRVI
Maravai LifeSciences Announces November 2025 Investor Conference Schedule

Nov 10, 2025, 8:00 AM EST - 2 months ago

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:26 PM EST - 2 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2025 Earnings Call Transcript

Maravai LifeSciences Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:01 PM EST - 2 months ago

Maravai LifeSciences Reports Third Quarter 2025 Financial Results

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

Oct 29, 2025, 7:52 AM EDT - 2 months ago

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025

Oct 22, 2025, 4:01 PM EDT - 2 months ago

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 11:36 PM EDT - 5 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 4:05 PM EDT - 5 months ago

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

Jul 28, 2025, 5:08 PM EDT - 5 months ago

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences

Jul 2, 2025, 8:49 AM EDT - 6 months ago

Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences

APP QUBT SWKS

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

Jun 25, 2025, 4:01 PM EDT - 7 months ago

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation

Jun 17, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

Jun 15, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

Jun 12, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

Jun 10, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect

Jun 8, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out

Jun 5, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 7 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation

May 29, 2025, 10:05 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 8 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect

May 25, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation

May 22, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025, 4:22 PM EDT - 8 months ago

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

Maravai LifeSciencesReleases 2024 Sustainability Report

May 21, 2025, 4:05 PM EDT - 8 months ago

Maravai LifeSciencesReleases 2024 Sustainability Report

Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025, 4:05 PM EDT - 8 months ago

Maravai LifeSciences Releases 2024 Sustainability Report

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

May 20, 2025, 8:00 AM EDT - 8 months ago

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect

May 18, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 15, 2025, 10:00 AM EDT - 8 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

May 13, 2025, 1:29 PM EDT - 8 months ago

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript

May 13, 2025, 12:03 AM EDT - 8 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript

Maravai Lifesciences Reports First Quarter 2025 Financial Results

May 12, 2025, 4:06 PM EDT - 8 months ago

Maravai Lifesciences Reports First Quarter 2025 Financial Results

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

May 5, 2025, 5:47 AM EDT - 8 months ago

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

May 1, 2025, 7:30 AM EDT - 9 months ago

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Apr 19, 2025, 7:36 AM EDT - 9 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

johnkimble
johnkimble Jan. 7 at 2:02 PM
$MRVI she is just getting started here comes the breakout!
0 · Reply
DARKP00L
DARKP00L Jan. 5 at 7:34 PM
$MRVI this stock is seeing a surge in interest. Market volatility might ensue!
0 · Reply
JohnStocksNY
JohnStocksNY Jan. 3 at 5:05 PM
Aptamer has signed a licensing agreement with $MRVI and stock (of Aptamer) has gained 36.7%
0 · Reply
JohnStocksNY
JohnStocksNY Jan. 3 at 4:59 PM
Wells Fargo Maintains Overweight on $MRVI
0 · Reply
SecessionS
SecessionS Dec. 25 at 2:36 PM
$MRVI The investment case increasingly rests on operational credibility rather than long‑range promises. Execution gaps should narrow meaningfully over coming quarters. Momentum becomes sustainable only with dependable execution. In short, this remains an execution‑driven story with meaningful but conditional upside.
2 · Reply
johnkimble
johnkimble Dec. 24 at 11:36 AM
$MRVI a sleeper stock going over $8 next year
1 · Reply
InvestorWisdom
InvestorWisdom Dec. 22 at 4:01 PM
$MRVI new product gaining traction. Upcoming reports should prove the growth trend… “We expect TriLink to deliver double digit sequential revenue growth in the fourth quarter," said Bernd Brust, CEO, Maravai LifeSciences. “The work we’ve done to reset, refocus, and strengthen the company positions us to deliver attractive financial results in the fourth quarter and 2026 while continuing to serve our customers with the same level of dedication we’ve had in the past."
0 · Reply
johnkimble
johnkimble Dec. 19 at 6:12 AM
$MRVI we will be adding some more with a target over $7
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:26 PM
Wells Fargo has updated their rating for Maravai LifeSciences ( $MRVI ) to Overweight with a price target of 4.5.
0 · Reply
CopiousCope
CopiousCope Dec. 11 at 9:18 PM
$MIGI next is $MRVI hidden gem imo been in
0 · Reply
CopiousCope
CopiousCope Dec. 11 at 7:19 PM
$BEAT $CADL $MIGI $MRVI
0 · Reply
CopiousCope
CopiousCope Dec. 11 at 6:45 PM
$MIGI good conference, revenue, float, volume, bull run, everything’s here. AH party 🥳 $BEAT good swing get in now $CADL swing $MRVI just needs volume, good float and ready to run.
0 · Reply
CopiousCope
CopiousCope Dec. 11 at 3:02 PM
$MIGI let er run today no worries $CADL ill jump in $MRVI needs volume, nice float, imo will hit soon
0 · Reply
CopiousCope
CopiousCope Dec. 11 at 2:41 PM
$MIGI morning dip discount m? $MRVI wait til this gets volume 😭 gold waiting
0 · Reply
CopiousCope
CopiousCope Dec. 11 at 2:33 PM
$BBGI rip, good run, push? $MIGI Here we go $MRVI that float 👀 + guaranteed growth.
0 · Reply
InvestorWisdom
InvestorWisdom Dec. 10 at 2:42 PM
$MRVI charts look good. Trying to break resistance this am
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 3 at 8:42 PM
$MRVI Share Price: $3.47 Contract Selected: Jun 18, 2026 $2.5 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.61 – $1.97 Potential Upside: 79% ROI Time to Expiration: 196 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Estimize
Estimize Nov. 27 at 9:00 PM
Wall St is expecting -0.07 EPS for $MRVI Q4 [Reporting 02/25 AMC] http://www.estimize.com/intro/mrvi?chart=historical&metric_name=eps&utm_c
0 · Reply
Sly15
Sly15 Nov. 21 at 10:03 PM
$MRVI i like how this CEO rolls
0 · Reply
Sly15
Sly15 Nov. 21 at 5:54 PM
$MRVI This one is going to go. The CEO is going to make it happen here. $7 is right around the corner, and I think this can be $15 in 12 months.
1 · Reply
johnkimble
johnkimble Nov. 18 at 12:17 PM
$MRVI with all of the shares being bought by the CEO it’s also an easy buy below $4
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Nov. 17 at 11:50 PM
$MRVI CEO purchased 216,212 shares at $3.25 for a total of $702,689. Brust Bernd now owns 2,466,771 shares. https://ceo-buys.com
0 · Reply